Expression of CD44s, CD44v6, and hyaluronan across the spectrum of normal-hyperplasia-carcinoma in breast

被引:24
作者
Afify, Alaa [1 ]
McNiel, Maaya A. [1 ]
Braggin, Jacquelyn [1 ]
Bailey, Helen [1 ]
Paulino, Augusto F. [2 ]
机构
[1] Univ Calif Davis, Med Ctr, Dept Med Pathol & Lab Med, Sacramento, CA 95817 USA
[2] Genzyme Genet, Dept Pathol, New York, NY USA
关键词
hyaluronan; CD44s; CD44v6; breast cancer;
D O I
10.1097/PAI.0b013e318047df6d
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Background: The interaction between transmembrane receptors on epithelial tumor cells and the surrounding extracellular matrix molecules is important in tumor progression and metastasis. This interaction is best exemplified by the relationship of the receptor CD44 and the extracellular matrix component hyaluronan (HA). This study seeks to evaluate the expression and the correlation of CD44s, CD44v6, and HA in normal, hyperplastic, and malignant breast epithelium and stroma. Materials and Methods: Archival paraffin-embedded tissue from cases of normal breast tissue (n = 10), intraductal hyperplasia without atypia (n = 13), ductal carcinoma in situ (DCIS) (n = 24), stage I infiltrating ductal carcinoma (n = 28), stage II infiltrating ductal carcinoma (n = 31), and their corresponding positive lymph nodes were retrieved from the surgical pathology files. Tissue sections were evaluated for the expression of CD44s, CD44v6, and HA in the epithelial and stromal cells by immunohistochemistry. Results: Ductal epithelial cells and myoepithelial cells expressed CD44s in all cases of normal and benign breast tissue. The expression of CD44s in breast epithelium progressively decreased with increasing deviation from normal histology: 83% in DCIS, 46% in stage I ductal carcinoma and 26% in stage II ductal carcinoma. The reverse trend was observed for CD44v6 in ductal epithelium: 0% in normal breast, 15% in intraductal hyperplasia, 100% in DCIS, 82% in stage I infiltrating ductal carcinoma, 94% in stage II carcinoma, and 100% of metastatic carcinoma in the lymph nodes. HA was noted exclusively in the stroma but not in the epithelial cells. HA was faintly expressed in the intralobular stroma of normal breast tissue, confined to a narrow faint band adjacent to intraductal hyperplasia and localized to a broad well-defined band around DCIS. Stromal HA staining was more diffuse and intense in infiltrating carcinomas and was particularly pronounced surrounding the metastatic deposits in lymph nodes. Conclusions: This study demonstrates decreased expression of CD44s accompanied by increased expression of CD44v6 and increased stromal HA in breast cancer. These findings suggest that CD44s, CD44v6, and HA play complementary roles in the development and progression of breast cancer.
引用
收藏
页码:121 / 127
页数:7
相关论文
共 48 条
[1]  
Afify Alaa M, 2005, Ann Diagn Pathol, V9, P312, DOI 10.1016/j.anndiagpath.2005.07.004
[2]   Expression of CD44S and CD44v5 is more common in stage III than in stage I serous ovarian carcinomas [J].
Afify, AM ;
Ferguson, AW ;
Davila, RM ;
Werness, BA .
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2001, 9 (04) :309-314
[3]  
AFIFY AM, 2005, APPL IMM MOL MORPPH, V14, P328
[4]  
[Anonymous], 2005, BREAST CANC FACTS FI
[5]   DENSITY-DEPENDENT EXPRESSION OF HYALURONIC-ACID BINDING TO VASCULAR CELLS-INVITRO [J].
ANTONELLI, A ;
DAMORE, PA .
MICROVASCULAR RESEARCH, 1991, 41 (02) :239-251
[6]   Expression of CD44s, CD44v3 and CD44v6 in benign and malignant breast lesions: correlation and colocalization with hyaluronan [J].
Auvinen, P ;
Tammi, R ;
Tammi, M ;
Johansson, R ;
Kosma, VM .
HISTOPATHOLOGY, 2005, 47 (04) :420-428
[7]   Gains and losses of CD44 expression during breast carcinogenesis and tumour progression [J].
Bankfalvi, A ;
Terpe, HJ ;
Breukelmann, D ;
Bier, B ;
Rempe, D ;
Pschadka, G ;
Krech, R ;
Böcker, W .
HISTOPATHOLOGY, 1998, 33 (02) :107-116
[8]   Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas [J].
Berner, HS ;
Suo, Z ;
Risberg, B ;
Villman, K ;
Karlsson, MG ;
Nesland, JM .
HISTOPATHOLOGY, 2003, 42 (06) :546-554
[9]   HYALURONAN (HYALURONIC-ACID) AND HYALURONECTIN IN THE EXTRACELLULAR-MATRIX OF HUMAN BREAST CARCINOMAS - COMPARISON BETWEEN INVASIVE AND NONINVASIVE AREAS [J].
BERTRAND, P ;
GIRARD, N ;
DELPECH, B ;
DUVAL, C ;
DANJOU, J ;
DAUCE, JP .
INTERNATIONAL JOURNAL OF CANCER, 1992, 52 (01) :1-6
[10]   Secretory products of breast cancer cells upregulate hyaluronan production in a human osteoblast cell line [J].
Bose, Nandita ;
Masellis, Anna M. .
CLINICAL & EXPERIMENTAL METASTASIS, 2005, 22 (08) :629-642